1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Subject:  Cancer

Results 1-12 of 12 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12019Autophagy modulators: Mechanistic aspects and drug delivery systemsTavakol, S.; Ashrafizadeh, M.; Deng, S. ; Azarian, M.; Abdoli, A.; Motavaf, M.; Poormoghadam, D.; Khanbabaei, H.; Ghasemipour Afshar, E.; Mandegary, A.; Pardakhty, A.; Yap, C.T. ; Mohammadinejad, R.; Prem Kumar, A. 
2Oct-2011Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathwaysKannaiyan, R.; Manu, K.A. ; Chen, L.; Li, F.; Rajendran, P.; Subramaniam, A.; Lam, P.; Kumar, A.P. ; Sethi, G.
320-Oct-2021Editing SOX genes by CRISPR-cas: Current insights and future perspectivesDehshahri, Ali; Biagioni, Alessio; Bayat, Hadi; Lee, E. Hui Clarissa ; Hashemabadi, Mohammad; Fekri, Hojjat Samareh; Zarrabi, Ali; Mohammadinejad, Reza; Kumar, Alan Prem 
428-Jun-2022Emerging role of exosomes in cancer progression and tumor microenvironment remodelingPaskeh, Mahshid Deldar Abad; Entezari, Maliheh; Mirzaei, Sepideh; Zabolian, Amirhossein; Saleki, Hossein; Naghdi, Mohamad Javad; Sabet, Sina; Khoshbakht, Mohammad Amin; Hashemi, Mehrdad; Hushmandi, Kiavash; Sethi, Gautam ; Zarrabi, Ali; Kumar, Alan Prem ; Tan, Shing Cheng; Papadakis, Marios; Alexiou, Athanasios; Islam, Md Asiful; Mostafavi, Ebrahim; Ashrafizadeh, Milad
52019FBXW7 in cancer: What has been unraveled thus far?Sailo, B.L.; Banik, K.; Girisa, S.; Bordoloi, D.; Fan, L. ; Halim, C.E. ; Wang, H. ; Kumar, A.P. ; Zheng, D.; Mao, X.; Sethi, G. ; Kunnumakkara, A.B.
615-Nov-2012Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancerPrasannan, R.; Kalesh, K.A.; Shanmugam, M.K. ; Nachiyappan, A.; Ramachandran, L.; Nguyen, A.H.; Kumar, A.P. ; Lakshmanan, M.; Ahn, K.S.; Sethi, G.
71-Dec-2023PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerGlaviano, A; Foo, ASC; Lam, HY ; Yap, KCH ; Jacot, W; Jones, RH; Eng, H ; Nair, MG; Makvandi, P; Geoerger, B; Kulke, MH; Baird, RD; Prabhu, JS; Carbone, D; Pecoraro, C; Teh, DBL; Sethi, G ; Cavalieri, V; Lin, KH; Javidi-Sharifi, NR; Toska, E; Davids, MS; Brown, JR; Diana, P; Stebbing, J; Fruman, DA; Kumar, AP 
82013Role of NF-κB in tumorigenesisShanmugam, M.K. ; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
91-Dec-2013Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerShrimali, D.; Shanmugam, M.K. ; Kumar, A.P. ; Zhang, J.; Tan, B.K.H.; Ahn, K.S.; Sethi, G.
1028-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
1115-Feb-2012Thymoquinone: Potential cure for inflammatory disorders and cancerWoo, C.C.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
121-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.